\
&
Contact us
\
&
Contact us
This was 3 years ago
Locationvirtual
ProgrammesThis information webinar on European Research Council (ERC) Advanced Grants 2023 Call for proposals is organised by the National Contact Points (NCPs) for ERC in Belgium (NCP-FNRS and NCP Flanders) to inform potential applicants and host institutions. It is also aimed at researchers who are considering applying in the future.
The ERC Advanced Grant Call 2023 is expected to open in December (opening date: 08/12/2022) with a deadline on 23 May 2023 (tentative dates). The call will be open to established, leading researchers of any nationality and from any field of research (bottom-up approach), with a track-record of significant research achievements in the last 10 years. There is no minimum or maximum age limit. The amount of the grant is up to € 2.5 million for 5 years (or up to €3.5 million in specific cases). More information on ERC Advanced Grants.
Participation to the session is free but restricted to researchers wishing to apply with a Belgian Host Institution, or staff members of Belgian Host Institutions. Registration is mandatory.
The recordings and slides are available on the webpage of the info session.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
